Nastech To Start Human Clinical Trials on Intranasal Obesity Spray
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on June 07, 2006

How does PYY work?
Peptide YY is a naturally occurring hormone that is believed to function as a physiologic inhibitor of food intake. PYY is produced by specialized endocrinecells (L-cells) in the gut after a person eats and is believed to trigger the feeling of satiety, or fullness. Because PYY is a protein, initial studies focused on PYY delivery by injection. Utilizing its proprietary drug delivery technology, Nastech developed the nasal spray formulation of PYY as a unique, non-invasive treatment option for obesity.
This investigational drug is currently available for partnering (Merck bowed out early this year). For the development of another nasal spray, this time an intranasal parathyroid hormone for the treatment of osteoporosis, Nastech just received a $7 milion milestone payment from collaborator Procter & Gamble.
Permalink: Nastech To Start Human Clinical Trials on Intranasal Obesity Spray
Tags:
obesity osteoporosis biotech human nastech human+clinical clinical+trials nastech+start
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/23955








